AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 5,020.00
-100.00 (-1.95%)
Jun 12, 2026, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 141.03 billion as of June 12, 2026. Its market cap has decreased by -24.73% in one year.
Market Cap
141.03B
Enterprise Value
136.85B
Revenue
4.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,020.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 141.03B, a decrease of -66.68%. That is a compound annual growth rate of -14.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 141.03B | -43.89% |
| Dec 30, 2025 | 251.34B | 46.78% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hana Pharm | 158.18B |
| Hyundai Pharmaceutical | 158.04B |
| Daihan Pharmaceutical | 154.94B |
| Samil Pharmaceutical Co.,Ltd | 150.52B |
| HLB Pharmaceutical | 150.39B |
| Jeil Pharmaceutical Co.,Ltd | 147.90B |
| Dongwha Pharm.Co.,Ltd | 147.18B |
| Ilyang Pharmaceutical Co.,Ltd | 146.98B |